Cargando…
Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study
BACKGROUND: Clinical remission can be maintained after the discontinuation of biological disease-modifying antirheumatic drugs (bDMARDs) in some patients with rheumatoid arthritis (RA) (bDMARD-free remission (BFR)). It is unknown which bDMARD is advantageous for achieving BFR or under which conditio...
Autores principales: | Hashimoto, Motomu, Furu, Moritoshi, Yamamoto, Wararu, Fujimura, Takanori, Hara, Ryota, Katayama, Masaki, Ohnishi, Akira, Akashi, Kengo, Yoshida, Shuzo, Nagai, Koji, Son, Yonsu, Amuro, Hideki, Hirano, Toru, Ebina, Kosuke, Uozumi, Ryuji, Ito, Hiromu, Tanaka, Masao, Ohmura, Koichiro, Fujii, Takao, Mimori, Tsuneyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091083/ https://www.ncbi.nlm.nih.gov/pubmed/30075810 http://dx.doi.org/10.1186/s13075-018-1673-1 |
Ejemplares similares
-
Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-
por: Ebina, Kosuke, et al.
Publicado: (2018) -
Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center Cohort
por: Ishikawa, Yuki, et al.
Publicado: (2016) -
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
por: Ebina, Kosuke, et al.
Publicado: (2020) -
Increase of Hemoglobin Levels by Anti-IL-6 Receptor Antibody (Tocilizumab) in Rheumatoid Arthritis
por: Hashimoto, Motomu, et al.
Publicado: (2014) -
Inverse Association between Air Pressure and Rheumatoid Arthritis Synovitis
por: Terao, Chikashi, et al.
Publicado: (2014)